Thrombosis and Inflammation in Vessels Initiative (TIVI)
National Heart, Lung, and Blood Institute (NHLBI) · NCT06552767
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 5–100 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 1000
- US sites recruiting
- 1
- Study start
- November 22, 2024
- Record last updated
- October 6, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Background
Diseases related to the immune system, blood clots, and blood vessels can affect every part of the body. These diseases are now known to be interrelated: People who have strokes, blood clots in their legs, or autoimmune disease, for example, are at greater risk of complications in the heart, brain, and other organs. Researchers want to learn more about how these diseases start, how they change over time, and how they affect different organs.
Objective
To learn more about how inflammation and diseases of the blood vessels start and how they change over time.
Eligibility
People aged 5 years and older with a disease related to blood clots, the immune system, or blood vessels. Healthy relatives of people with these diseases and unrelated healthy volunteers are also needed.
Design
Participants will have a baseline visit: They will provide a medical history, physical exam and blood test. All other tests and procedures are optional; these may be spread over more than 1 day:
Tests of heart and lung function.
Fill in a family tree form.
Imaging scans
Treadmill or bike stress tests and a 6-minute walk test.
Tests of blood pressure and the flow of blood through vessels.
Photos of the face and body.
Eye exams, with photos taken of the retina.
Saliva and urine samples.
Biopsies (tissues samples) of the skin and fat.
Tests of thinking and mental function.
Evaluations by other medical specialists.
Participants may opt to return for repeat testing for up to 90 months (7.5 years).
Some visits may be done by telehealth.
Conditions: Cardiovascular Diseases; Vascular Diseases
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
- INCLUSION CRITERIA:
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Age >= 5 years at the time of consent
- Ability of subject or Legally Authorized Representative (LAR) as applicable to understand and the willingness to sign a written informed consent document
In addition, the following cohort-specific inclusion criteria apply:
Affected Subjects
-Known or possible thrombotic, immune, or vascular disorder after review of the subject s medical records and/or discussion of medical history
Relatives of Affected Subjects
-Being a relative of an affected subject
Unrelated Healthy Controls
-In good general health as evidenced by medical history
EXCLUSION CRITERIA
An individual who meets any of the following criteria will be excluded from participation in this study:
-Any condition that in the opinion of the Investigator would warrant exclusion
Unrelated Healthy Controls
- Unrelated healthy volunteers who decline to have blood drawn and/or tissue studies or who do not consent to have samples stored for future research
- Cognitively impaired individuals
Recruiting US locations
National Institutes of Health Clinical Center
Bethesda, MD 20892
Site contact: Yogendra Kanthi, M.D. · 301-529-7297 · yogen.kanthi@nih.gov
Study contacts (from the official record)
- Jessenia C Campos, R.N. · (301) 402-0300 · jessenia.campos@nih.gov
- Yogendra Kanthi, M.D. · (301) 529-7297 · yogen.kanthi@nih.gov
Similar studies in Maryland
All heart & blood pressure studies in Maryland →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Study of Intravenous ZMA001 in Healthy Subjects
National Heart, Lung, and Blood Institute (NHLBI)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 1
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
National Heart, Lung, and Blood Institute (NHLBI)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 18–99
- RecruitingHealthy volunteers
BoxX-NoAF Clinical Trial
AtriCure, Inc.
- Location
- Baltimore, MD + 30 other US sites
- Eligibility basics
- Ages 65+
- RecruitingPhase 2
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Pfizer
- Location
- Baltimore, MD + 27 other US sites
- Eligibility basics
- Ages 18–79